Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of I…
Industry Peers
Drug Manufacturers - Specialty & Generic| Headline | Source | Time |
|---|---|---|
Yesterday | ||
This Trade Offers Two Ways To Profit From Hims & Hers Stock A cash-secured put on Hims & Hers stock is one way to potentially buy the stock for a discount or achieve a healthy return. | ||
This week | ||
Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should Know Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $35.15, moving +2.24% from the previous trading session. | ||
1 Stock Under $50 with Exciting Potential and 2 Facing Challenges The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers. | ||
Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now? Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects. | ||
HIMS Stock Logs Worst Week In 2 Months — Turns To Peptides Campaign Ahead Of Key FDA Meeting An FDA advisory committee will review seven peptides for possible inclusion on the Section 503A Bulks List on July 23-24. | ||
Older | ||